Twin Strand Bio

Developer of DNA sequencing technology to identify genomic mutations

placeSeattle, Washington, United States calendar_todayFounded 2015 groups70 employees language twinstrandbio.com

Registered entities

Investor mix

11 investors on record; lead investors include Madrona, S32.

Investor typeCountShare
Venture capital545%
Private equity327%
Other / undisclosed327%
Coming soon